Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2-(methylthio)-1-(2-(pentyloxy)phenyl)ethenyl)-1h-imidazole
2. Neticonazole
3. Ss-717
4. Ss717
1. 130773-02-3
2. Atolant
3. Neticonazole Hydrochloride [jan]
4. Neticonazole (hydrochloride)
5. Pkf582zh6p
6. Ss-717
7. 1-[(e)-2-methylsulfanyl-1-(2-pentoxyphenyl)ethenyl]imidazole;hydrochloride
8. 1-[2-methylsulfanyl-1-(2-pentoxyphenyl)ethenyl]imidazole Hydrochloride
9. Neticonazole Hydrochloride (jan)
10. Ss717
11. Unii-pkf582zh6p
12. Newral
13. Atolant (tn)
14. (e)-(1-(2-pentyloxyphenyl)-1-imidazolyl-2-methylthio)ethylene Hydrochloride
15. (e)-1-(2-(methylthio)-1-(2-(pentyloxy)phenyl)ethenyl)-1h-imidazole Monohydrochloride
16. Schembl36681
17. Chebi:31900
18. (e)-1-(2-(methylthio)-1-(2-(pentyloxy)phenyl)vinyl)-1h-imidazole Hydrochloride
19. Ss 717
20. Akos037515631
21. Ccg-267906
22. Neticonazole Hydrochloride [mi]
23. 1h-imidazole, 1-(2-(methylthio)-1-(2-(pentyloxy)phenyl)ethenyl)-, Monohydrochloride, (e)-
24. Bs-15159
25. Neticonazole Hydrochloride [mart.]
26. Neticonazole Hydrochloride [who-dd]
27. Hy-128365
28. Cs-0099200
29. S4878
30. D01620
31. Q27286599
32. 1-((e)-1-(2-amoxyphenyl)-2-(methylthio)vinyl)imidazole Hydrochloride
33. 1-{(e)-2-(methylsulfanyl)-1-[2-(pentyloxy)phenyl]vinyl}-1h-imidazol-3-ium Chloride
34. 1-{(e)-2-(methylsulfanyl)-1-[2-(pentyloxy)phenyl]vinyl}-1h-imidazole Hydrochloride
35. 1-{(e)-2-(methylthio)-1-[2-(pentyloxy)phenyl]vinyl}-1h-imidazol-3-ium Chloride
36. 1-{(e)-2-(methylthio)-1-[2-(pentyloxy)phenyl]vinyl}-1h-imidazole Hydrochloride
Molecular Weight | 338.9 g/mol |
---|---|
Molecular Formula | C17H23ClN2OS |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 8 |
Exact Mass | 338.1219622 g/mol |
Monoisotopic Mass | 338.1219622 g/mol |
Topological Polar Surface Area | 52.4 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 322 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Neticonazole Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neticonazole Hydrochloride, including repackagers and relabelers. The FDA regulates Neticonazole Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neticonazole Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Neticonazole Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Neticonazole Hydrochloride supplier is an individual or a company that provides Neticonazole Hydrochloride active pharmaceutical ingredient (API) or Neticonazole Hydrochloride finished formulations upon request. The Neticonazole Hydrochloride suppliers may include Neticonazole Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Neticonazole Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Neticonazole Hydrochloride Drug Master File in Japan (Neticonazole Hydrochloride JDMF) empowers Neticonazole Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Neticonazole Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Neticonazole Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Neticonazole Hydrochloride suppliers with JDMF on PharmaCompass.
Neticonazole Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Neticonazole Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Neticonazole Hydrochloride GMP manufacturer or Neticonazole Hydrochloride GMP API supplier for your needs.
A Neticonazole Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Neticonazole Hydrochloride's compliance with Neticonazole Hydrochloride specifications and serves as a tool for batch-level quality control.
Neticonazole Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Neticonazole Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Neticonazole Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Neticonazole Hydrochloride EP), Neticonazole Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Neticonazole Hydrochloride USP).
LOOKING FOR A SUPPLIER?